News
OS Therapies forms subsidiary OS Animal Health to commercialize OST-HER2 for canine osteosarcoma: New York Friday, May 16, 2025, 14:00 Hrs [IST] OS Therapies, a clinical-stage imm ...
STEERLife redefines potent drug development with clean, green, continuous processing: Our Bureau, Bengaluru Friday, May 16, 2025, 13:45 Hrs [IST] STEERLife, the life sciences divi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback